Lantheus Medical Imaging   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: North Billerica MA United States (1956)
Status: No NME R&D (1956)

Organization Overview

First Clinical Trial
2003
NCT00162344
First Marketed Drug
1974
xenon xe-133
First NDA Approval
1997
samarium-153 lexidronam (quadramet)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LANTHEUS MEDCL | LANTHEUS MEDICAL | Lantheus Medical Imaging | Medical Monitor - Lantheus Medical Imaging